HomeNewsBusinessEconomic Survey 2023: Indian aviation reaches pre-Covid levels in Dec with 150 lakh flyers
Trending Topics

Economic Survey 2023: Indian aviation reaches pre-Covid levels in Dec with 150 lakh flyers

The survey said that the Indian civil aviation market has great potential due to the growing demand from the middle class, growth in population and tourism

January 31, 2023 / 16:14 IST
Story continues below Advertisement

The Indian aviation sector reached the average pre-Covid level in December 2022, said the Economic Survey for 2022-23, tabled in Parliament on January 31.

The total number of passengers carried in December 2022 stood at 150.1 lakh, which was 6.4 percent higher than the pre-Covid average for 11 months from April 2019 to February 2020, the Survey said. In November 2022, total air cargo tonnage stood at 2.5 lakh tonnes, which was 89 percent of the pre-Covid levels.

Story continues below Advertisement

The Survey reviews how the economy performed in this fiscal year and the road ahead for the next year.

The Survey said the civil aviation market has great potential due to the growing demand from the middle class, growth in population and tourism. It added that higher disposable incomes, favourable demographics, and greater penetration of aviation infrastructure will help grow the market in India.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show